• Date: December 2-7, 2019
  • Location: Kigali Convention Centre, Kigali, Rwanda

The 20th International Conference on AIDS and STIs in Africa (ICASA) will take place in Kigali, Rwanda, at the Kigali Convention Centre from Monday, December 2 through Saturday, December 7, 2019.

ICAP staff will present oral presentations and poster sessions, and host satellite sessions. See below for full list of ICAP activities.

Click for full conference information.

Jump to Poster Sessions.

 

Satellite and Abstract Driven Sessions:

 

Tuesday, December 3

 

Satellite: “General and Key Population Surveys: Why are they needed and what can they teach us?

Tuesday, December 3, 7:00 – 8:30 a.m.
Prudence Mabele (MH 2+ Corridor)
http://www.professionalabstracts.com/icasa2019/iplanner/#/session/123

Organizer:
ICAP at Columbia University

Moderators: TBA
Panelists: Solange Baptiste, ITPC; Chinedu Osita Agbakwuru University of Maryland; Veronicah Mugisha, ICAP

Summary:
General and key population HIV surveys are essential to gathering the information needed to guide the HIV response. For generalized epidemics, nationally representative household surveys have measured HIV prevalence, incidence, and viral load measures. For key populations, integrated bio-behavioral surveys (IBBS) have provided critical data on such populations including risk behaviors, the size and location of these often hard-to-reach populations as well as HIV-related biomarkers. These surveys utilize different methodologies and implementation strategies. Both types of surveys can provide governments, funders, policymakers, program implementers, civil society groups and community members with a detailed picture of the current epidemics and can suggest who to prioritize with HIV prevention and treatment services as well as how to best deliver these services. This satellite session will share key insights into rationale, methods and findings from population surveys, review lessons learned, and explore the ways in which the data generated can change the course of epidemics and save lives.

Agenda:

  • Welcome and Objectives of the Session
    Wafaa El-Sadr, ICAP
  • Introduction
    Ambassador-at-Large Deborah L Birx, PEPFAR
  • General Population Surveys: Rationale, Methods and Lessons Learned
    Jessica Justman, ICAP
  • Use of Survey Results to Inform Policy and Programs
    Sabin Nsanzimana, RBC Rwanda
Satellite: “HIV drug resistance (HIVDR) survey implementation in Africa: implementation experience and evidence for policy decisions”

Tuesday, December 3, 6:30 p.m. – 8:30 p.m.
Kigali (Auditorium)
http://www.professionalabstracts.com/icasa2019/iplanner/#/session/221

Organizers:
ICAP at Columbia University

Co-Chairs:
Bereket Alemayehu, ICAP at Columbia University
Juliana de Fatima Da Silva, CDC Atlanta

Moderators:
Amithab Suthar, CDC Atlanta
Gentille Musengimana, Rwanda RBC

Summary:
Rising levels of drug-resistant HIV as a consequence of the expansion of access to antiretroviral treatment services poses a great challenge to control of the HIV epidemic in Africa. Consequently, the World Health Organization (WHO) recommends that scale-up of antiretroviral treatment programmes is always accompanied by a robust assessment of HIV drug resistance (HIVDR) emergence and transmission, and surveillance was identified as one of the five strategic objectives of the HIVDR Global Action Plan 2017–2021. To achieve this, the WHO has developed a generic surveillance protocol to facilitate the collection of timely and accurate nationally representative HIVDR data to better detect trends and improve programme planning and decision making. While several countries have implemented the survey using the standardized and nationally-representative methodology recommended by WHO, many other countries have insufficient technical capacity in their national HIV program to implement the survey. ICAP at Columbia University, in collaboration with the US Centers for Disease Control and Prevention and ministries of health, has developed and implemented HIVDR surveys based on the WHO recommendations to measure, at a population level, both transmitted and acquired HIVDR in several African countries. It is essential that HIVDR data and lessons learned from these implementations and others are shared to build capacity and guide future survey implementation.

Presentations:

  • Framing remarks and introduction to the session by the Co-chairs
    Bereket Alemayehu ICAP
  • National HIVDR Survey implementation and public health actions: Results and lessons learned from Eswatini
    MOH Eswatini Representative
  • National HIVDR Survey implementation and public health actions: Results and lessons learned from Rwanda
    Rwanda MOH Representative
  • National HIVDR Survey implementation and post-survey activities: Results and lessons learned from Lesotho
    MOH Lesotho Representative
  • HIVDR surveillance activities in the European region: Results and lessons learned from Switzerland
    Heiner Bucher, University of Basel, Switzerland
  • Q&A session
  • HIV drug resistance surveillance in PEPFAR: adapting methodology to meet programmatic needs
    Juliana de Fatima Da Silva, CDC Atlanta
  • ICAP’s approach and experience in building capacity for the HIV Drug Resistance survey: Protocol development, survey implementation and post-survey activities
    Claude Muvunyi ICAP
  • HIV DR survey as source of evidence-based recommendations for HIV treatment guidelines: Guiding principle and implementation considerations
    Nathan Ford, WHO Geneva and Steve Kanters, WHO

 

Wednesday, December 4

 

Satellite: ICAP at Columbia University: Differentiated Service Delivery and Advanced HIV Disease

Wednesday, December 4, 7:00 – 8:30 a.m.
Cheick sidy Modibo Kane (MH 1)
http://www.professionalabstracts.com/icasa2019/iplanner/#/session/43

Organizers:
ICAP at Columbia University

Summary:
In recent years, differentiated service delivery (DSD) models have been developed to improve the quality and efficiency of HIV programs. Much progress has been made in designing efficient and people-centered DSD models for patients who are doing well on treatment. In contrast, there has been less innovation about service delivery for patients with advanced HIV disease who still comprise almost one-third of people initiating ART. ICAP at Columbia University is a leader in the design, development, implementation and evaluation of HIV programs, working hand in hand with Ministries of Health (MOH) and diverse partners. ICAP’s HIV Coverage, Quality and Impact Network (CQUIN) brings countries together to share DSD innovations and to work together towards sustainable high quality HIV programs. This satellite will convene implementers from MOH, PLHIV organizations, implementing partners, donors and other stakeholders. Using an interactive panel format, the session will highlight the importance of DSD for advanced HIV disease and showcase innovations and global best practices.

 

Friday, December 6

 

Abstract Driven Session: Limited Use of Dual Contraception Among Women of Reproductive Age in Eswatini

Friday, December 6, 4:45 – 6:15 p.m.
MH3
http://www.professionalabstracts.com/icasa2019/iplanner/#/presentation/52

Affiliations:
ICAP at Columbia University
Ministry of Health – Eswatini

Summary:
Use of dual contraception is recommended for protection against pregnancy, HIV, and sexually transmitted infections (STIs) among women of reproductive age (15-19 years). In a high HIV/STI prevalence settings, dual protection remains critical. This study analyzed uptake and predictors of dual contraception among women of reproductive age in Eswatini. 

 

Poster Sessions

Related Items